Topical Therapies for Pruritus

被引:85
作者
Elmariah, Sarina B. [2 ]
Lerner, Ethan A. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02129 USA
[2] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
基金
美国国家卫生研究院; 比尔及梅琳达.盖茨基金会;
关键词
STABILIZED ATOPIC-DERMATITIS; PIMECROLIMUS CREAM 1-PERCENT; 3; MU-G/G; TACROLIMUS OINTMENT; PEDIATRIC-PATIENTS; DOUBLE-BLIND; HUMAN SKIN; CALCINEURIN INHIBITORS; BRACHIORADIAL PRURITUS; INTRACTABLE PRURITUS;
D O I
10.1016/j.sder.2011.04.008
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Itch, or pruritus, is the predominant symptom associated with acute and chronic cutaneous disease, and in some cases may be debilitating. To date, there is no single universally effective anti-itch treatment. Because the pathophysiology of itch in most cutaneous or systemic disorders remains unclear, antipruritic therapy is often directed against a variety of targets, including the epidermal barrier, immune system, or the nervous system. Topical therapy is the mainstay of dermatologic management of acute or localized itch or in patients with contraindications to systemic therapies. This review will summarize current topical therapies to treat pruritus and discuss potential future therapies. Semin Cutan Med Surg 30:118-126 (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:118 / 126
页数:9
相关论文
共 87 条
[1]
Abramovits William, 2006, J Drugs Dermatol, V5, P236
[2]
PERINAL - A NEW NO-TOUCH SPRAY TO RELIEVE THE SYMPTOMS OF PRURITUS ANI [J].
ALLENBY, CF ;
JOHNSTONE, RS ;
CHATFIELD, S ;
PIKE, LC ;
TIDY, G .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1993, 8 (04) :184-187
[3]
Effects of TS-022, a newly developed prostanoid DPI receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice [J].
Arai, Iwao ;
Takaoka, Akiko ;
Hashimoto, Yuki ;
Honma, Yusuke ;
Koizumi, Chie ;
Futaki, Nobuko ;
Sugimoto, Masanori ;
Takahashi, Nobutaka ;
Inoue, Tomoyuki ;
Nakanishi, Yutaka ;
Sakurai, Takanobu ;
Tanami, Toru ;
Yagi, Makoto ;
Ono, Naoya ;
Nakaike, Shiro .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 556 (1-3) :207-214
[4]
Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis [J].
Arellano, Felix M. ;
Wentworth, Charles E. ;
Arana, Alejandro ;
Fernandez, Carlos ;
Paul, Carle F. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (04) :808-816
[5]
Brachioradial pruritus - an enigmatic entity [J].
Barry, R ;
Rogers, S .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (06) :637-638
[6]
Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study [J].
Berth-Jones, J ;
Damstra, RJ ;
Golsch, S ;
Livden, JK ;
Van Hooteghem, O ;
Allegra, F ;
Parker, CA .
BRITISH MEDICAL JOURNAL, 2003, 326 (7403) :1367-1370
[7]
Treatment of pruritus with topically applied opiate receptor antagonist [J].
Bigliardi, Paul L. ;
Stammer, Holger ;
Jost, Gerhard ;
Rufli, Theo ;
Buchner, Stanislaw ;
Bigliardi-Qi, Mei .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (06) :979-988
[8]
Bikowski J, 2009, J DRUGS DERMATOL, V8, P1037
[9]
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children [J].
Boguniewicz, M ;
Fiedler, VC ;
Raimer, S ;
Lawrence, ID ;
Leung, DYM ;
Hanifin, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :637-644
[10]
Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle [J].
Breneman, Debra ;
Fleischer, Alan B., Jr. ;
Abramovits, William ;
Zeichner, Joshua ;
Gold, Michael H. ;
Kirsner, Robert S. ;
Shull, Toni E. ;
Crowe, Andrew W. ;
Jaracz, Eileen ;
Hanifin, Jon M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (06) :990-999